Supporting Implementation of Comprehensive HIV Prevention, Care and Treatment Programs in Bomu Hospital Affiliated Sites, Coptic Hospitals, and Faith-Based Sites in the Eastern Slums of Nairobi, Kenya under the President’s Emergency Plan for AI | CDC RFA GH16 1690

Opportunity Information: Apply for CDC RFA GH16 1690

This funding opportunity (CDC RFA GH16-1690) is a CDC cooperative agreement under PEPFAR (the President's Emergency Plan for AIDS Relief) focused on strengthening comprehensive HIV prevention, care, and treatment services delivered through private and faith-based health facilities linked to Bomu Hospital, Coptic Hospitals, and other faith-based sites. The geographic emphasis is Nairobi, specifically including the eastern Nairobi slums, with additional supported sites referenced in the Coast region and Kisumu. The central public health intent is to reduce new HIV infections among adults and children served by CDC-supported populations, improve clinical outcomes for people living with HIV (PLHIV), and drive higher rates of viral suppression, which is positioned as the key pathway to lowering HIV incidence as well as HIV-related illness and death.

The program scope is framed around delivering comprehensive, high-quality HIV services across the prevention-to-treatment continuum. In practical terms, this kind of FOA typically expects implementers to ensure strong HIV testing and counseling services, effective linkage to care for people newly diagnosed, rapid initiation and sustained delivery of antiretroviral therapy (ART), and the retention and adherence support needed to achieve and maintain viral suppression. Because the sites include private and faith-based facilities serving densely populated informal settlements, the emphasis implies services that are accessible, consistent, and adapted to the realities of urban slum settings, including high patient volumes, mobility, stigma, and barriers to follow-up care. The end goal is epidemic impact: fewer new infections, fewer HIV-associated complications, and longer, healthier lives for PLHIV through reliable treatment success.

This particular posting also includes an important administrative note: the text provided reflects an amendment that is informational only, and CDC is not accepting new applications for award under this announcement. The amendment specifically adds language about HIV epidemic control under a section described as "Other National Public Health Priorities and Strategies," signaling that the program is aligned with the broader strategic direction of achieving epidemic control through high coverage of testing, treatment, and viral suppression. In other words, the amendment does not reopen competition; it clarifies how the work fits within evolving national and global HIV strategy priorities.

From a funding and structure standpoint, the opportunity is categorized as discretionary funding with a cooperative agreement mechanism, meaning CDC would typically have substantial involvement in oversight, technical direction, and performance monitoring compared with a more hands-off grant. The CFDA number listed is 93.067, the expected number of awards is one, and the award ceiling is $18,500,000, indicating a single large implementer would be responsible for coordinating or directly delivering the package of services across the named networks of facilities. The original closing date shown is February 4, 2016, and the creation date is December 4, 2015, which places the competition in a prior funding cycle even though the amendment language was later used to update the public notice.

Eligibility is intentionally broad and includes a wide range of U.S. and non-U.S. entities, reflecting the reality that large-scale HIV service delivery often requires partnerships across government, academia, clinical providers, and community organizations. Eligible applicants listed include multiple levels of government (state, county, city/township, special districts, regional organizations, and U.S. territories), public and private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit organizations (including small businesses), individuals, and a variety of special institutional categories (for example, HBCUs and other minority-serving institutions). It also explicitly includes non-domestic (non-U.S.) entities and "other" groups such as Ministries of Health, tribal epidemiology centers, urban Indian health organizations, research institutions performing non-research activities, colleges and universities, community-based organizations, faith-based organizations, hospitals, and small, minority-, and women-owned businesses. Taken together, that eligibility language suggests CDC wanted to allow both local Kenyan implementers and international partners to compete, as long as they could credibly deliver and manage comprehensive HIV programming at scale in the targeted facilities and communities.

In summary, the opportunity supports a single, large cooperative agreement aimed at comprehensive HIV prevention and treatment implementation in selected private and faith-based health facility networks serving high-need urban populations in Nairobi (including eastern slums) and additional referenced regions. The performance expectation is improved service delivery and measurable clinical outcomes, especially viral suppression among PLHIV, as the core driver of reduced transmission and lower HIV-related morbidity and mortality. The current notice is not a call for new applications; it is an informational amendment that updates the framing to explicitly reference HIV epidemic control as a guiding priority.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Supporting Implementation of Comprehensive HIV Prevention, Care and Treatment Programs in Bomu Hospital Affiliated Sites, Coptic Hospitals, and Faith-Based Sites in the Eastern Slums of Nairobi, Kenya under the President’s Emergency Plan for AI" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-12-04.
• Applicants must submit their applications by 2016-02-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $18,500,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH16 1690

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: